- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
According to our latest study, the global Diagnostic Radiopharmaceuticals market size was valued at USD 4512 million in 2022 and is forecast to a readjusted size of USD 7059.4 million by 2029 with a CAGR of 6.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
This report is a detailed and comprehensive analysis for global Diagnostic Radiopharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Diagnostic Radiopharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Diagnostic Radiopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Diagnostic Radiopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Diagnostic Radiopharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diagnostic Radiopharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diagnostic Radiopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma and Bracco Imaging, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Diagnostic Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Technetium 99
Fluorine 18
Other
Market segment by Application
Oncology
Cardiology
Other
Major players covered
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostic Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diagnostic Radiopharmaceuticals, with price, sales, revenue and global market share of Diagnostic Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the Diagnostic Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Diagnostic Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diagnostic Radiopharmaceuticals.
Chapter 14 and 15, to describe Diagnostic Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Technetium 99
1.3.3 Fluorine 18
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Diagnostic Radiopharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Other
1.5 Global Diagnostic Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Diagnostic Radiopharmaceuticals Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Diagnostic Radiopharmaceuticals Sales Quantity (2018-2029)
1.5.3 Global Diagnostic Radiopharmaceuticals Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business
2.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
2.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cardinal Health Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
2.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Curium Pharma
2.3.1 Curium Pharma Details
2.3.2 Curium Pharma Major Business
2.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
2.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Curium Pharma Recent Developments/Updates
2.4 Jubilant Pharma
2.4.1 Jubilant Pharma Details
2.4.2 Jubilant Pharma Major Business
2.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
2.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Jubilant Pharma Recent Developments/Updates
2.5 Bracco Imaging
2.5.1 Bracco Imaging Details
2.5.2 Bracco Imaging Major Business
2.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
2.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bracco Imaging Recent Developments/Updates
2.6 Advanced Accelerator Applications
2.6.1 Advanced Accelerator Applications Details
2.6.2 Advanced Accelerator Applications Major Business
2.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product and Services
2.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Advanced Accelerator Applications Recent Developments/Updates
2.7 SIEMENS
2.7.1 SIEMENS Details
2.7.2 SIEMENS Major Business
2.7.3 SIEMENS Diagnostic Radiopharmaceuticals Product and Services
2.7.4 SIEMENS Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 SIEMENS Recent Developments/Updates
2.8 China Isotope & Radiation
2.8.1 China Isotope & Radiation Details
2.8.2 China Isotope & Radiation Major Business
2.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
2.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 China Isotope & Radiation Recent Developments/Updates
2.9 Dongcheng Pharmaceutical Group
2.9.1 Dongcheng Pharmaceutical Group Details
2.9.2 Dongcheng Pharmaceutical Group Major Business
2.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product and Services
2.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Dongcheng Pharmaceutical Group Recent Developments/Updates
2.10 Lantheus
2.10.1 Lantheus Details
2.10.2 Lantheus Major Business
2.10.3 Lantheus Diagnostic Radiopharmaceuticals Product and Services
2.10.4 Lantheus Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lantheus Recent Developments/Updates
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Eli Lilly Recent Developments/Updates
3 Competitive Environment: Diagnostic Radiopharmaceuticals by Manufacturer
3.1 Global Diagnostic Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023)
3.2 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
3.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Diagnostic Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2022
3.4.2 Top 6 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2022
3.5 Diagnostic Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Diagnostic Radiopharmaceuticals Market: Region Footprint
3.5.2 Diagnostic Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Diagnostic Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Diagnostic Radiopharmaceuticals Market Size by Region
4.1.1 Global Diagnostic Radiopharmaceuticals Sales Quantity by Region (2018-2029)
4.1.2 Global Diagnostic Radiopharmaceuticals Consumption Value by Region (2018-2029)
4.1.3 Global Diagnostic Radiopharmaceuticals Average Price by Region (2018-2029)
4.2 North America Diagnostic Radiopharmaceuticals Consumption Value (2018-2029)
4.3 Europe Diagnostic Radiopharmaceuticals Consumption Value (2018-2029)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value (2018-2029)
4.5 South America Diagnostic Radiopharmaceuticals Consumption Value (2018-2029)
4.6 Middle East and Africa Diagnostic Radiopharmaceuticals Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
5.2 Global Diagnostic Radiopharmaceuticals Consumption Value by Type (2018-2029)
5.3 Global Diagnostic Radiopharmaceuticals Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
6.2 Global Diagnostic Radiopharmaceuticals Consumption Value by Application (2018-2029)
6.3 Global Diagnostic Radiopharmaceuticals Average Price by Application (2018-2029)
7 North America
7.1 North America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
7.2 North America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
7.3 North America Diagnostic Radiopharmaceuticals Market Size by Country
7.3.1 North America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2029)
7.3.2 North America Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
8.2 Europe Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
8.3 Europe Diagnostic Radiopharmaceuticals Market Size by Country
8.3.1 Europe Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2029)
8.3.2 Europe Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
10.2 South America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
10.3 South America Diagnostic Radiopharmaceuticals Market Size by Country
10.3.1 South America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2029)
10.3.2 South America Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Diagnostic Radiopharmaceuticals Market Drivers
12.2 Diagnostic Radiopharmaceuticals Market Restraints
12.3 Diagnostic Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Diagnostic Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Diagnostic Radiopharmaceuticals
13.3 Diagnostic Radiopharmaceuticals Production Process
13.4 Diagnostic Radiopharmaceuticals Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Diagnostic Radiopharmaceuticals Typical Distributors
14.3 Diagnostic Radiopharmaceuticals Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Diagnostic Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 4. Cardinal Health Major Business
Table 5. Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
Table 6. Cardinal Health Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Cardinal Health Recent Developments/Updates
Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. GE Healthcare Major Business
Table 10. GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
Table 11. GE Healthcare Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GE Healthcare Recent Developments/Updates
Table 13. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Curium Pharma Major Business
Table 15. Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 16. Curium Pharma Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Curium Pharma Recent Developments/Updates
Table 18. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Jubilant Pharma Major Business
Table 20. Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 21. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Jubilant Pharma Recent Developments/Updates
Table 23. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 24. Bracco Imaging Major Business
Table 25. Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
Table 26. Bracco Imaging Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bracco Imaging Recent Developments/Updates
Table 28. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 29. Advanced Accelerator Applications Major Business
Table 30. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product and Services
Table 31. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Advanced Accelerator Applications Recent Developments/Updates
Table 33. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 34. SIEMENS Major Business
Table 35. SIEMENS Diagnostic Radiopharmaceuticals Product and Services
Table 36. SIEMENS Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. SIEMENS Recent Developments/Updates
Table 38. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 39. China Isotope & Radiation Major Business
Table 40. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
Table 41. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. China Isotope & Radiation Recent Developments/Updates
Table 43. Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. Dongcheng Pharmaceutical Group Major Business
Table 45. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product and Services
Table 46. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Dongcheng Pharmaceutical Group Recent Developments/Updates
Table 48. Lantheus Basic Information, Manufacturing Base and Competitors
Table 49. Lantheus Major Business
Table 50. Lantheus Diagnostic Radiopharmaceuticals Product and Services
Table 51. Lantheus Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Lantheus Recent Developments/Updates
Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly Major Business
Table 55. Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
Table 56. Eli Lilly Diagnostic Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Global Diagnostic Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Diagnostic Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Diagnostic Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Diagnostic Radiopharmaceuticals Production Site of Key Manufacturer
Table 63. Diagnostic Radiopharmaceuticals Market: Company Product Type Footprint
Table 64. Diagnostic Radiopharmaceuticals Market: Company Product Application Footprint
Table 65. Diagnostic Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 66. Diagnostic Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Diagnostic Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Diagnostic Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Diagnostic Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Diagnostic Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Diagnostic Radiopharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Diagnostic Radiopharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Diagnostic Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Diagnostic Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Diagnostic Radiopharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Diagnostic Radiopharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Diagnostic Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Diagnostic Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Diagnostic Radiopharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Diagnostic Radiopharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Diagnostic Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Diagnostic Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Diagnostic Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Diagnostic Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Diagnostic Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Diagnostic Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Diagnostic Radiopharmaceuticals Raw Material
Table 126. Key Manufacturers of Diagnostic Radiopharmaceuticals Raw Materials
Table 127. Diagnostic Radiopharmaceuticals Typical Distributors
Table 128. Diagnostic Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Type in 2022
Figure 4. Technetium 99 Examples
Figure 5. Fluorine 18 Examples
Figure 6. Other Examples
Figure 7. Global Diagnostic Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Application in 2022
Figure 9. Oncology Examples
Figure 10. Cardiology Examples
Figure 11. Other Examples
Figure 12. Global Diagnostic Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Diagnostic Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Diagnostic Radiopharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Diagnostic Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Diagnostic Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Diagnostic Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Diagnostic Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Diagnostic Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Diagnostic Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Diagnostic Radiopharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Diagnostic Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Diagnostic Radiopharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Diagnostic Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Diagnostic Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Diagnostic Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 54. China Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Diagnostic Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Diagnostic Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Diagnostic Radiopharmaceuticals Market Drivers
Figure 75. Diagnostic Radiopharmaceuticals Market Restraints
Figure 76. Diagnostic Radiopharmaceuticals Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2022
Figure 79. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 80. Diagnostic Radiopharmaceuticals Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
